New breast cancer treatment trials could be available in the next few years according to The Institute of Cancer Research (ICR), following new studies into how to stop the spread of the cancer.
The research showed the protein, endosialin, to be a key vehicle for the cancer around the body. It is claimed that detecting the protein in the bloodstream may be an important biomarker test for high-risk breast cancer.
Clare Isacke, team leader at the ICR, explained more about the new research to Paul Ross.
"We know that for a cancer to grow in the breast it needs a blood supply, and of course the problem of having a new blood supply in the tumor is it also provides a potential road in which the cancer cells can escape.
"It was these little cells, called parasites, that are actually helping cancer cells get into those blood vessels.
"If we can block that expression of endosialin, or block the activity of that protein on the cell surface, that could provide the opportunity to try and limit the spread of breast cancer, and we've got hope for that because there are already some treatments that are being tried out.
"The speed at which these discoveries are being made is increasing, so I would be hopeful that within a few years we will be moving this into very specific trials."
Listen to the full interview to find out more